Bill Kelly

Prior to joining Vicarious Surgical, Bill served as CFO at Exosome Diagnostics, overseeing its transition to a commercial stage company and managing the negotiation and execution of the company's sale to Bio-Techne. Prior to Exosome, Bill served as CFO of Repligen Corporation driving growth in market cap of nearly 10x through restructuring of the business.